Enteral feeding tolerance during pharmacologic neuromuscular blockade.
Roland N DickersonJulie E FarrarSaskya ByerlyDina M FilibertoPublished in: Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition (2023)
A common misperception is that critically ill patients who receive paralytic therapy will not tolerate enteral nutrition. As a result, some clinicians empirically withhold enteral feedings for critically ill patients who receive neuromuscular blocker pharmacotherapy (NMB). The intent of this review is to examine the evidence regarding enteral feeding tolerance for critically ill patients given NMB. Studies evaluating enteral feeding during paralytic therapy are provided and critiqued. Evidence examining enteral feeding tolerance during NMB is limited. Enteral feeding intolerance is more likely attributable to the underlying illnesses and concurrent opioid analgesia, sedation, and vasopressor therapies. Most critically ill patients can be successfully fed during NMB. Prokinetic pharmacotherapy may be warranted in some patients.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- physical activity
- newly diagnosed
- palliative care
- chronic pain
- prognostic factors
- intensive care unit
- peritoneal dialysis
- mechanical ventilation
- patient reported outcomes
- mesenchymal stem cells
- rectal cancer
- locally advanced
- extracorporeal membrane oxygenation